EDIT Message Board Post 9190966 | Editas Medicine Inc.
home / stock / edit / edit message board
sarahslabo
(investorshub)
Posted on: May/02/2022 21:43:49
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168726613
1106: $EDIT-202, a Multiplexed CRISPR-Cas12a Gene-Edited iPSC-Derived NK
News, Short Squeeze, Breakout and More Instantly...
-
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...
-
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a clinical-stage gene editing company, today announced t...
-
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will host a conference call and webcast on Wednesday, May 8, 2024, at 8:00 a.m. ET to discuss results for the first quarter 2024 a...